Only 19% use AI predictive models in cancer care despite strong belief in impact; 2026 Oncology Care Index highlights reimbursement, training, funding barriers.
|Articles|June 7, 2020
AstraZeneca's Adrian Kilcoyne Discusses Small Lung Cancer (pt.2)
Author(s)Mary Caffrey
Advertisement
Adrian Kilcoyne MD MBA MPH, vice president, US Medical Affairs and HEOR, oncology, AstraZeneca, discusses small lung cancer and the presentation he held at the annual ASCO20 meeting in late May.
Advertisement
Related to this article
AACR Cancer Progress Report 2026 highlights a 35% U.S. cancer death decline, new FDA advances, persistent disparities, and urgent calls for stronger NIH/NCI funding.
Northwell Health reports rising 9/11-linked cancer rates tied to Ground Zero debris, as oncology teams expand screening and treatment for survivors and responders.
National Alliance names Jenny Goins interim CEO after former leader’s arrest; details emerge on charges, firing timeline, and impact on healthcare policy circles.
Hispanic HIV incidence rose 16.8% in antisanctuary counties after the 2018 public charge announcement, relative to baseline counties, a new study found.
A review of randomized clinical trials, nonrandomized trials and case reports suggests that the inflammatory bowel disease risk from treatment with IL-17 inhibitors is low.
From a 95% remission rate in Japan to $81.6 billion in U.S. savings since 2015 — a data-driven look at where biosimilars stand today, and where the gaps remain.
AI pathology tool measures lung cancer treatment response after neoadjuvant chemoimmunotherapy with 91% accuracy, speeding NSCLC care while needing review for complete response.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Biosimilars are reshaping pricing and drug development — the numbers behind it
2
The IBD risk among patients with hidrandentitis suppurtiva treated with IL-17 inhibitors: Low but not nothing
3
National Alliance names interim head after arrest of its president
4
Community oncologists are turning to AI, but not all of them use predictive models
5